Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)
China flag China · Delayed Price · Currency is CNY
14.33
-0.23 (-1.58%)
Nov 21, 2024, 3:00 PM CST

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-422.97-189.451,0911,059806.12604.96
Upgrade
Depreciation & Amortization
154.06154.06139.5393.2284.5544.99
Upgrade
Other Amortization
0.190.190.190.20.230.2
Upgrade
Loss (Gain) From Sale of Assets
0.040.040.111.030.22-0.13
Upgrade
Asset Writedown & Restructuring Costs
1,2441,24410.227.2352-2.97
Upgrade
Loss (Gain) From Sale of Investments
85.5885.58-24.1-24.57-10.55-10.69
Upgrade
Provision & Write-off of Bad Debts
-3.32-3.32-0.423.22--
Upgrade
Other Operating Activities
115.45-1.96-99.4387.4755.6719.69
Upgrade
Change in Accounts Receivable
163.36163.36-1,456-148.2-345.27-202.11
Upgrade
Change in Inventory
213.28213.28-731.57-444.05-1,223-1,230
Upgrade
Change in Accounts Payable
224.66224.661,71046.8211.23-61.64
Upgrade
Change in Other Net Operating Assets
-21.25-21.25-15.113.4511.515.1
Upgrade
Operating Cash Flow
1,5031,619595.45683.63-565.85-841.38
Upgrade
Operating Cash Flow Growth
32.41%171.93%-12.90%---
Upgrade
Capital Expenditures
-649.94-419.07-470.08-440.76-294.36-115.41
Upgrade
Sale of Property, Plant & Equipment
-1.40.150.110.540.120.31
Upgrade
Cash Acquisitions
----13.87--25.58
Upgrade
Investment in Securities
-2,269-757.4736.06610.72-887.57-24.94
Upgrade
Other Investing Activities
-8.9914.3433.4213.519.0311.99
Upgrade
Investing Cash Flow
-2,930-1,162-400.5170.14-1,173-153.62
Upgrade
Short-Term Debt Issued
----3,0732,059
Upgrade
Long-Term Debt Issued
-3,3993,3582,1261,266-
Upgrade
Total Debt Issued
4,6033,3993,3582,1264,3392,059
Upgrade
Short-Term Debt Repaid
-----2,311-1,011
Upgrade
Long-Term Debt Repaid
--3,094-3,441-2,687--
Upgrade
Total Debt Repaid
-3,018-3,094-3,441-2,687-2,311-1,011
Upgrade
Net Debt Issued (Repaid)
1,585305.39-83.41-560.942,0281,048
Upgrade
Issuance of Common Stock
--0.3741.17227.355.99
Upgrade
Repurchase of Common Stock
-5.72-5.72-1.13-0.87-1.04-2.39
Upgrade
Common Dividends Paid
-208.52-248.47-226.65-191.75-261.21-100.64
Upgrade
Other Financing Activities
-6.84---200-19.57-
Upgrade
Financing Cash Flow
1,36451.2-310.81-912.391,973951.38
Upgrade
Foreign Exchange Rate Adjustments
144.2683.18-16.1120.05-9.884.41
Upgrade
Net Cash Flow
81.64591.51-131.97-38.57224.78-39.21
Upgrade
Free Cash Flow
853.111,200125.37242.87-860.21-956.79
Upgrade
Free Cash Flow Growth
2.93%857.27%-48.38%---
Upgrade
Free Cash Flow Margin
22.00%30.53%3.38%6.59%-29.51%-38.74%
Upgrade
Free Cash Flow Per Share
0.530.760.080.15-0.54-0.61
Upgrade
Cash Income Tax Paid
29,887108.8691.0146.06-5.82-134.78
Upgrade
Levered Free Cash Flow
873.11,068-540.91-186.72-1,220-1,079
Upgrade
Unlevered Free Cash Flow
920.881,119-504.75-129.08-1,184-1,065
Upgrade
Change in Net Working Capital
-1,687-1,549841.2560.571,5631,417
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.